Times Square Capital Management, LLC Morpho Sys Ag Transaction History

Times Square Capital Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$21.56 - $30.66 $25 Million - $35.5 Million	-1,158,619 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$24.81 - $30.33 $16 Million - $19.5 Million	-644,000 Reduced 35.73%	1,158,619 $32.8 Million
Q3 2020 Nov 06, 2020	BUY	$30.28 - $35.72 $7.82 Million - $9.22 Million	258,229 Added 16.72%	1,802,619 $56.6 Million
Q2 2020 Aug 07, 2020	BUY	$24.08 - $33.35 $2.75 Million - $3.81 Million	114,381 Added 8.0%	1,544,390 $48.9 Million
Q1 2020 May 08, 2020	BUY	$18.86 - $37.36 $3.04 Million - $6.03 Million	161,280 Added 12.71%	1,430,009 $35.1 Million
Q4 2019 Feb 05, 2020	SELL	$26.07 - $36.32 $35,741 - $49,794	-1,371 Reduced 0.11%	1,268,729 $45.3 Million
Q3 2019 Nov 05, 2019	BUY	$24.18 - $31.58 $16.3 Million - $21.2 Million	672,100 Added 112.39%	1,270,100 $34.9 Million
Q2 2019 Aug 02, 2019	SELL	$23.24 - $26.76 $2.8 Million - $3.22 Million	-120,500 Reduced 16.77%	598,000 $14.4 Million
Q1 2019 May 10, 2019	SELL	$22.55 - $29.84 $290,895 - $384,936	-12,900 Reduced 1.76%	718,500 $16.3 Million
Q4 2018 Feb 14, 2019	SELL	$21.96 - $31.02 $1.46 Million - $2.06 Million	-66,400 Reduced 8.32%	731,400 $18.5 Million
Q3 2018 Nov 14, 2018	BUY	$26.64 - $35.66 $4.2 Million - $5.63 Million	157,800 Added 24.66%	797,800 $0
Q2 2018 Aug 14, 2018	BUY	$25.15 - $30.6 $16.1 Million - $19.6 Million	640,000 New	640,000 $19.4 Million

1.84M

79.8K

688K

Ticker MOR
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 136,614,000
Description
MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.